Category Archives: Ranbaxy

Lipitor generic predictions

As Nov 30 approaches and Pfizer prepares to lose exclusivity on Lipitor, analysts are offering a variety of theories [Settelement bwt Ranbaxy and Pfizer] =============================================================== ….Two of Ranbaxy’s India plants have been banned by the USFDA. While Ranbaxy is confident … Continue reading

Posted in Daily interesting IP news, Ranbaxy | Tagged , , | Leave a comment

Azilsartan medoxomil – opposition – India

Indian patent journal (of September 9th 2011) has some new post grant oppositions filed under section 25(2) of Patent Act 1970. The controller may generally publish such post oppositions filed under section 25(2)in official journal. Ranbaxy, Lupin and MSN have filed post grant opposition … Continue reading

Posted in Daily interesting IP news, Ranbaxy | Tagged , , , , , | 4 Comments